Corporate Board Profile
Tech Score: 25/100
1 mention(s) identify SAMUEL WADSWORTH, PH.D. as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| PRECISION BIOSCIENCES INC | 2024-04-25 | Dr. Wadsworth has authored over 80 peer-reviewed papers including some of the earliest published work on adeno-associated viral (“AAV”) vectors for gene therapies and owns over a dozen patents related to AAV vectors for gene therapies. Dr. Wadsworth’s academic credentials include a Ph.D. from the University of Chicago. | Dr. Wadsworth has authored over 80 peer-reviewed papers including early work on AAV vectors for gene therapies, owns patents related to gene therapies, and has a Ph.D. He has significant scientific and technical expertise in biotechnology, which involves advanced technical skills likely including programming or related technical knowledge. |
| Filing Date | Source Excerpt |
|---|---|
| 2022-03-29 | Dr. Wadsworth has authored over 80 peer-reviewed papers including some of the earliest published work on adeno-associated viral vectors for gene therapies and owns over a dozen patents related to AAV vectors for gene therapies. He has a Ph.D. from the University of Chicago. |
| 2023-03-23 | Samuel Wadsworth, Ph.D., has served on our Board of Directors since November 2021. Dr. Wadsworth has authored over 80 peer-reviewed papers including some of the earliest published work on adeno-associated viral vectors for gene therapies... Dr. Wadsworth’s academic credentials include a Ph.D. from the University of Chicago and a B.A. from Southern Illinois University. |
| 2023-12-04 | Samuel Wadsworth, Ph.D.(11) Consists of 196,933 shares of common stock underlying options exercisable within 60 days of November 15, 2023. |
| 2024-04-25 | Dr. Wadsworth has authored over 80 peer-reviewed papers including some of the earliest published work on adeno-associated viral (“AAV”) vectors for gene therapies and owns over a dozen patents related to AAV vectors for gene therapies. Dr. Wadsworth’s academic credentials include a Ph.D. from the University of Chicago. |
Data sourced from SEC filings. Last updated: 2026-03-09